Valuation
P/E Ratio -4,33x
P/B Ratio 0,85x
P/S Ratio 9,66x
P/FCF Ratio -3,71x
Margins
Gross Margin 99,26 %
Operating Margin -318,70 %
Net Margin -315,71 %

| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
IEX |
RNA
|
USD
|
30.07.2026 19:59
|
11,48 USD
| - |
NASDAQ |
RNA
|
USD
|
30.07.2026 19:59
|
11,46 USD
| - |
The following funds have invested in Atrium Therapeutics, Inc. - Common Stock:
Fund | Vol. in million 3.684,89 | Percentage (%) 2,33 % |
Fund | Vol. in million 719,69 | Percentage (%) 0,49 % |
Fund | Vol. in million 1.403,50 | Percentage (%) 0,14 % |
Fund | Vol. in million 66,29 | Percentage (%) 0,03 % |
Fund | Vol. in million 1.078,79 | Percentage (%) 0,0091 % |
NASDAQ
| Name | Symbol |
|---|---|
| NASDAQ | RNA |